β-Defensin gene copy number variation in cattle
β-Defensins are peptides with antimicrobial roles, characterized by a conserved tertiary structure. Beyond antimicrobial functions, they exhibit diverse roles in both the immune response and fertility, including involvement in sperm maturation and function. Copy number variation (CNV) of β-defensin genes is extensive across mammals, including cattle, with possible implications for reproductive traits and disease resistance. In this study, we comprehensively catalogue 55 β-defensin genes in cattle. By constructing a phylogenetic tree to identify human orthologues and lineage-specific expansions, we identify 1 : 1 human orthologues for 35 bovine β-defensins. We also discover extensive β-defensin gene CNV across breeds, with <i>DEFB103,</i> in particular, showing extensive multi-allelic CNV. By comparing β-defensin expression levels in testis from calves and adult bulls, we find that 14 β-defensins, including <i>DEFB103</i>, increase in expression during sexual maturation. Analysis of β-defensin gene expression levels in the caput of adult bull epididymis, and β-defensin gene copy number, in 94 matched samples shows expression levels of four β-defensins are correlated with genomic copy numbers, including <i>DEFB103</i>. We therefore demonstrate extensive CNV in bovine β-defensin genes, in particular <i>DEFB103</i>, with potential functional consequences for fertility.
Authors
- Kieran G. Meade (ORCID: https://orcid.org/0000-0002-3051-8586)
- John W. Oketch (ORCID: https://orcid.org/0000-0002-8020-0787)
- Seán Fair (ORCID: https://orcid.org/0000-0003-0085-1537)
- Edward J. Hollox (ORCID: https://orcid.org/0000-0002-0115-2298)
- Ozge Sidekli
Institutions
- University College Dublin (IE)
- University of Leicester (GB)
- University of Limerick (IE)
Publication Details
- Journal
- Royal Society Open Science
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1098/rsos.241154
- Citations
- 4
- Primary Topic
- Infant Nutrition and Health
- Type
- article
- Field-Weighted Citation Impact
- 1.24
Funders
- Wellcome Trust
- University of Leicester
- Biotechnology and Biological Sciences Research Council
- H2020 Marie Skłodowska-Curie Actions